HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations.

Abstract
Abacavir is an effective antiretroviral drug used to treat HIV-1 infection. Approximately 5% of patients treated with abacavir develop a hypersensitivity reaction that requires discontinuation of the drug. In an initial pharmacogenetic study conducted in a predominantly White male population, multiple markers in the human leukocyte antigen (HLA)-B chromosomal region were associated with hypersensitivity to abacavir. The HLA-B*5701 association has now been confirmed in White males in a subsequent, larger study (n=293, p=4.7 x 10(-18)) and is also observed in White females (n=56, p=6.8 x 10(-6)) and Hispanics (n=104, p=2.1 x 10(-4)). HLA-B*5701 was not associated with hypersensitivity in Blacks (n=78, p=0.27). HLA-B*5701 alone lacks sufficient predictive value to identify patients at risk for hypersensitivity to abacavir across diverse patient populations. Efforts are ongoing to identify markers with sufficient sensitivity and specificity to be clinically useful. Even after a marker set is identified, appropriate clinical identification and management of hypersensitivity to abacavir must remain the cornerstone of clinical practice.
AuthorsArlene R Hughes, Michael Mosteller, Aruna T Bansal, Kirstie Davies, Stephen A Haneline, Eric H Lai, Keith Nangle, Trevor Scott, William R Spreen, Liling L Warren, Allen D Roses, CNA30027 Study Team, CNA30032 Study Team
JournalPharmacogenomics (Pharmacogenomics) Vol. 5 Issue 2 Pg. 203-11 (Mar 2004) ISSN: 1462-2416 [Print] England
PMID15016610 (Publication Type: Comparative Study, Journal Article, Multicenter Study)
Chemical References
  • Anti-HIV Agents
  • Dideoxynucleosides
  • Genetic Markers
  • HLA-B Antigens
  • Tumor Necrosis Factor-alpha
  • abacavir
Topics
  • Anti-HIV Agents (adverse effects)
  • Black People (genetics)
  • Case-Control Studies
  • Dideoxynucleosides (adverse effects)
  • Drug Hypersensitivity (etiology, metabolism)
  • Female
  • Genetic Markers
  • Genetic Variation
  • Genotype
  • HLA-B Antigens (genetics)
  • Humans
  • Male
  • Polymorphism, Single Nucleotide
  • Retrospective Studies
  • Tumor Necrosis Factor-alpha (genetics)
  • White People (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: